nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosfomycin—Megacolon toxic—Irinotecan—colon cancer	0.158	0.158	CcSEcCtD
Fosfomycin—Megacolon—Irinotecan—colon cancer	0.08	0.08	CcSEcCtD
Fosfomycin—Megacolon toxic—Methotrexate—colon cancer	0.0785	0.0785	CcSEcCtD
Fosfomycin—Megacolon—Methotrexate—colon cancer	0.0399	0.0399	CcSEcCtD
Fosfomycin—Haematocrit decreased—Methotrexate—colon cancer	0.0176	0.0176	CcSEcCtD
Fosfomycin—Platelet count decreased—Capecitabine—colon cancer	0.0148	0.0148	CcSEcCtD
Fosfomycin—Blood bilirubin increased—Irinotecan—colon cancer	0.0139	0.0139	CcSEcCtD
Fosfomycin—Phosphatase alkaline increased—Irinotecan—colon cancer	0.0131	0.0131	CcSEcCtD
Fosfomycin—Haemoglobin decreased—Capecitabine—colon cancer	0.0128	0.0128	CcSEcCtD
Fosfomycin—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.011	0.011	CcSEcCtD
Fosfomycin—Deafness—Vincristine—colon cancer	0.0109	0.0109	CcSEcCtD
Fosfomycin—Blood bilirubin increased—Capecitabine—colon cancer	0.00929	0.00929	CcSEcCtD
Fosfomycin—Hearing impaired—Capecitabine—colon cancer	0.00923	0.00923	CcSEcCtD
Fosfomycin—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00881	0.00881	CcSEcCtD
Fosfomycin—Phosphatase alkaline increased—Capecitabine—colon cancer	0.00879	0.00879	CcSEcCtD
Fosfomycin—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00858	0.00858	CcSEcCtD
Fosfomycin—Dysuria—Vincristine—colon cancer	0.00791	0.00791	CcSEcCtD
Fosfomycin—Eosinophilia—Fluorouracil—colon cancer	0.00781	0.00781	CcSEcCtD
Fosfomycin—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.00734	0.00734	CcSEcCtD
Fosfomycin—Deafness—Capecitabine—colon cancer	0.00713	0.00713	CcSEcCtD
Fosfomycin—Rhinitis—Irinotecan—colon cancer	0.00661	0.00661	CcSEcCtD
Fosfomycin—Vaginal inflammation—Methotrexate—colon cancer	0.00654	0.00654	CcSEcCtD
Fosfomycin—Rhinitis—Fluorouracil—colon cancer	0.00633	0.00633	CcSEcCtD
Fosfomycin—Migraine—Capecitabine—colon cancer	0.00628	0.00628	CcSEcCtD
Fosfomycin—Pharyngitis—Fluorouracil—colon cancer	0.00627	0.00627	CcSEcCtD
Fosfomycin—Vaginal infection—Methotrexate—colon cancer	0.00618	0.00618	CcSEcCtD
Fosfomycin—Aplastic anaemia—Methotrexate—colon cancer	0.00614	0.00614	CcSEcCtD
Fosfomycin—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00575	0.00575	CcSEcCtD
Fosfomycin—Back pain—Vincristine—colon cancer	0.0057	0.0057	CcSEcCtD
Fosfomycin—Flatulence—Irinotecan—colon cancer	0.00566	0.00566	CcSEcCtD
Fosfomycin—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00563	0.00563	CcSEcCtD
Fosfomycin—Lymphadenopathy—Methotrexate—colon cancer	0.00557	0.00557	CcSEcCtD
Fosfomycin—Back pain—Irinotecan—colon cancer	0.00555	0.00555	CcSEcCtD
Fosfomycin—Asthma—Capecitabine—colon cancer	0.00551	0.00551	CcSEcCtD
Fosfomycin—Influenza—Capecitabine—colon cancer	0.00551	0.00551	CcSEcCtD
Fosfomycin—Dysuria—Capecitabine—colon cancer	0.00516	0.00516	CcSEcCtD
Fosfomycin—Myalgia—Vincristine—colon cancer	0.00502	0.00502	CcSEcCtD
Fosfomycin—Anaphylactic shock—Vincristine—colon cancer	0.00481	0.00481	CcSEcCtD
Fosfomycin—Infection—Vincristine—colon cancer	0.00478	0.00478	CcSEcCtD
Fosfomycin—Haematuria—Capecitabine—colon cancer	0.00469	0.00469	CcSEcCtD
Fosfomycin—Anaphylactic shock—Irinotecan—colon cancer	0.00469	0.00469	CcSEcCtD
Fosfomycin—Myalgia—Fluorouracil—colon cancer	0.00468	0.00468	CcSEcCtD
Fosfomycin—Infection—Irinotecan—colon cancer	0.00465	0.00465	CcSEcCtD
Fosfomycin—Anorexia—Vincristine—colon cancer	0.00459	0.00459	CcSEcCtD
Fosfomycin—Anaphylactic shock—Fluorouracil—colon cancer	0.00449	0.00449	CcSEcCtD
Fosfomycin—Anorexia—Irinotecan—colon cancer	0.00447	0.00447	CcSEcCtD
Fosfomycin—Infection—Fluorouracil—colon cancer	0.00446	0.00446	CcSEcCtD
Fosfomycin—Rhinitis—Capecitabine—colon cancer	0.00443	0.00443	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Vincristine—colon cancer	0.00438	0.00438	CcSEcCtD
Fosfomycin—Pharyngitis—Capecitabine—colon cancer	0.00438	0.00438	CcSEcCtD
Fosfomycin—Insomnia—Vincristine—colon cancer	0.00435	0.00435	CcSEcCtD
Fosfomycin—Paraesthesia—Vincristine—colon cancer	0.00432	0.00432	CcSEcCtD
Fosfomycin—Anorexia—Fluorouracil—colon cancer	0.00428	0.00428	CcSEcCtD
Fosfomycin—Insomnia—Irinotecan—colon cancer	0.00424	0.00424	CcSEcCtD
Fosfomycin—Paraesthesia—Irinotecan—colon cancer	0.00421	0.00421	CcSEcCtD
Fosfomycin—Decreased appetite—Vincristine—colon cancer	0.00418	0.00418	CcSEcCtD
Fosfomycin—Somnolence—Irinotecan—colon cancer	0.00417	0.00417	CcSEcCtD
Fosfomycin—Dyspepsia—Irinotecan—colon cancer	0.00412	0.00412	CcSEcCtD
Fosfomycin—Constipation—Vincristine—colon cancer	0.00411	0.00411	CcSEcCtD
Fosfomycin—Pain—Vincristine—colon cancer	0.00411	0.00411	CcSEcCtD
Fosfomycin—Asthma—Methotrexate—colon cancer	0.00411	0.00411	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00409	0.00409	CcSEcCtD
Fosfomycin—Decreased appetite—Irinotecan—colon cancer	0.00407	0.00407	CcSEcCtD
Fosfomycin—Eosinophilia—Methotrexate—colon cancer	0.00406	0.00406	CcSEcCtD
Fosfomycin—Insomnia—Fluorouracil—colon cancer	0.00406	0.00406	CcSEcCtD
Fosfomycin—Paraesthesia—Fluorouracil—colon cancer	0.00403	0.00403	CcSEcCtD
Fosfomycin—Constipation—Irinotecan—colon cancer	0.00401	0.00401	CcSEcCtD
Fosfomycin—Pain—Irinotecan—colon cancer	0.00401	0.00401	CcSEcCtD
Fosfomycin—Somnolence—Fluorouracil—colon cancer	0.00399	0.00399	CcSEcCtD
Fosfomycin—Dyspepsia—Fluorouracil—colon cancer	0.00395	0.00395	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Vincristine—colon cancer	0.00393	0.00393	CcSEcCtD
Fosfomycin—Decreased appetite—Fluorouracil—colon cancer	0.0039	0.0039	CcSEcCtD
Fosfomycin—Dysuria—Methotrexate—colon cancer	0.00384	0.00384	CcSEcCtD
Fosfomycin—Pain—Fluorouracil—colon cancer	0.00384	0.00384	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Irinotecan—colon cancer	0.00383	0.00383	CcSEcCtD
Fosfomycin—Abdominal pain—Vincristine—colon cancer	0.0038	0.0038	CcSEcCtD
Fosfomycin—Body temperature increased—Vincristine—colon cancer	0.0038	0.0038	CcSEcCtD
Fosfomycin—Flatulence—Capecitabine—colon cancer	0.00379	0.00379	CcSEcCtD
Fosfomycin—Back pain—Capecitabine—colon cancer	0.00372	0.00372	CcSEcCtD
Fosfomycin—Body temperature increased—Irinotecan—colon cancer	0.0037	0.0037	CcSEcCtD
Fosfomycin—Abdominal pain—Irinotecan—colon cancer	0.0037	0.0037	CcSEcCtD
Fosfomycin—Body temperature increased—Fluorouracil—colon cancer	0.00355	0.00355	CcSEcCtD
Fosfomycin—Haematuria—Methotrexate—colon cancer	0.00349	0.00349	CcSEcCtD
Fosfomycin—Asthenia—Vincristine—colon cancer	0.00345	0.00345	CcSEcCtD
Fosfomycin—Asthenia—Irinotecan—colon cancer	0.00336	0.00336	CcSEcCtD
Fosfomycin—Diarrhoea—Vincristine—colon cancer	0.00329	0.00329	CcSEcCtD
Fosfomycin—Myalgia—Capecitabine—colon cancer	0.00327	0.00327	CcSEcCtD
Fosfomycin—Pharyngitis—Methotrexate—colon cancer	0.00326	0.00326	CcSEcCtD
Fosfomycin—Diarrhoea—Irinotecan—colon cancer	0.00321	0.00321	CcSEcCtD
Fosfomycin—Dry mouth—Capecitabine—colon cancer	0.0032	0.0032	CcSEcCtD
Fosfomycin—Dizziness—Vincristine—colon cancer	0.00318	0.00318	CcSEcCtD
Fosfomycin—Pruritus—Fluorouracil—colon cancer	0.00317	0.00317	CcSEcCtD
Fosfomycin—Infection—Capecitabine—colon cancer	0.00312	0.00312	CcSEcCtD
Fosfomycin—Dizziness—Irinotecan—colon cancer	0.0031	0.0031	CcSEcCtD
Fosfomycin—Diarrhoea—Fluorouracil—colon cancer	0.00307	0.00307	CcSEcCtD
Fosfomycin—Vomiting—Vincristine—colon cancer	0.00306	0.00306	CcSEcCtD
Fosfomycin—Skin disorder—Capecitabine—colon cancer	0.00305	0.00305	CcSEcCtD
Fosfomycin—Rash—Vincristine—colon cancer	0.00303	0.00303	CcSEcCtD
Fosfomycin—Dermatitis—Vincristine—colon cancer	0.00303	0.00303	CcSEcCtD
Fosfomycin—Headache—Vincristine—colon cancer	0.00301	0.00301	CcSEcCtD
Fosfomycin—Anorexia—Capecitabine—colon cancer	0.00299	0.00299	CcSEcCtD
Fosfomycin—Vomiting—Irinotecan—colon cancer	0.00298	0.00298	CcSEcCtD
Fosfomycin—Dizziness—Fluorouracil—colon cancer	0.00297	0.00297	CcSEcCtD
Fosfomycin—Rash—Irinotecan—colon cancer	0.00295	0.00295	CcSEcCtD
Fosfomycin—Dermatitis—Irinotecan—colon cancer	0.00295	0.00295	CcSEcCtD
Fosfomycin—Headache—Irinotecan—colon cancer	0.00294	0.00294	CcSEcCtD
Fosfomycin—Nausea—Vincristine—colon cancer	0.00286	0.00286	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00286	0.00286	CcSEcCtD
Fosfomycin—Vomiting—Fluorouracil—colon cancer	0.00285	0.00285	CcSEcCtD
Fosfomycin—Insomnia—Capecitabine—colon cancer	0.00284	0.00284	CcSEcCtD
Fosfomycin—Rash—Fluorouracil—colon cancer	0.00283	0.00283	CcSEcCtD
Fosfomycin—Dermatitis—Fluorouracil—colon cancer	0.00283	0.00283	CcSEcCtD
Fosfomycin—Paraesthesia—Capecitabine—colon cancer	0.00282	0.00282	CcSEcCtD
Fosfomycin—Headache—Fluorouracil—colon cancer	0.00281	0.00281	CcSEcCtD
Fosfomycin—Nausea—Irinotecan—colon cancer	0.00278	0.00278	CcSEcCtD
Fosfomycin—Back pain—Methotrexate—colon cancer	0.00277	0.00277	CcSEcCtD
Fosfomycin—Dyspepsia—Capecitabine—colon cancer	0.00276	0.00276	CcSEcCtD
Fosfomycin—Decreased appetite—Capecitabine—colon cancer	0.00273	0.00273	CcSEcCtD
Fosfomycin—Pain—Capecitabine—colon cancer	0.00268	0.00268	CcSEcCtD
Fosfomycin—Constipation—Capecitabine—colon cancer	0.00268	0.00268	CcSEcCtD
Fosfomycin—Nausea—Fluorouracil—colon cancer	0.00267	0.00267	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Capecitabine—colon cancer	0.00256	0.00256	CcSEcCtD
Fosfomycin—Abdominal pain—Capecitabine—colon cancer	0.00248	0.00248	CcSEcCtD
Fosfomycin—Body temperature increased—Capecitabine—colon cancer	0.00248	0.00248	CcSEcCtD
Fosfomycin—Myalgia—Methotrexate—colon cancer	0.00244	0.00244	CcSEcCtD
Fosfomycin—Anaphylactic shock—Methotrexate—colon cancer	0.00233	0.00233	CcSEcCtD
Fosfomycin—Infection—Methotrexate—colon cancer	0.00232	0.00232	CcSEcCtD
Fosfomycin—Skin disorder—Methotrexate—colon cancer	0.00227	0.00227	CcSEcCtD
Fosfomycin—Asthenia—Capecitabine—colon cancer	0.00225	0.00225	CcSEcCtD
Fosfomycin—Anorexia—Methotrexate—colon cancer	0.00223	0.00223	CcSEcCtD
Fosfomycin—Pruritus—Capecitabine—colon cancer	0.00222	0.00222	CcSEcCtD
Fosfomycin—Diarrhoea—Capecitabine—colon cancer	0.00215	0.00215	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00213	0.00213	CcSEcCtD
Fosfomycin—Insomnia—Methotrexate—colon cancer	0.00211	0.00211	CcSEcCtD
Fosfomycin—Paraesthesia—Methotrexate—colon cancer	0.0021	0.0021	CcSEcCtD
Fosfomycin—Somnolence—Methotrexate—colon cancer	0.00208	0.00208	CcSEcCtD
Fosfomycin—Dizziness—Capecitabine—colon cancer	0.00207	0.00207	CcSEcCtD
Fosfomycin—Dyspepsia—Methotrexate—colon cancer	0.00205	0.00205	CcSEcCtD
Fosfomycin—Decreased appetite—Methotrexate—colon cancer	0.00203	0.00203	CcSEcCtD
Fosfomycin—Pain—Methotrexate—colon cancer	0.002	0.002	CcSEcCtD
Fosfomycin—Vomiting—Capecitabine—colon cancer	0.00199	0.00199	CcSEcCtD
Fosfomycin—Rash—Capecitabine—colon cancer	0.00198	0.00198	CcSEcCtD
Fosfomycin—Dermatitis—Capecitabine—colon cancer	0.00198	0.00198	CcSEcCtD
Fosfomycin—Headache—Capecitabine—colon cancer	0.00196	0.00196	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Methotrexate—colon cancer	0.00191	0.00191	CcSEcCtD
Fosfomycin—Nausea—Capecitabine—colon cancer	0.00186	0.00186	CcSEcCtD
Fosfomycin—Body temperature increased—Methotrexate—colon cancer	0.00185	0.00185	CcSEcCtD
Fosfomycin—Abdominal pain—Methotrexate—colon cancer	0.00185	0.00185	CcSEcCtD
Fosfomycin—Asthenia—Methotrexate—colon cancer	0.00167	0.00167	CcSEcCtD
Fosfomycin—Pruritus—Methotrexate—colon cancer	0.00165	0.00165	CcSEcCtD
Fosfomycin—Diarrhoea—Methotrexate—colon cancer	0.0016	0.0016	CcSEcCtD
Fosfomycin—Dizziness—Methotrexate—colon cancer	0.00154	0.00154	CcSEcCtD
Fosfomycin—Vomiting—Methotrexate—colon cancer	0.00148	0.00148	CcSEcCtD
Fosfomycin—Rash—Methotrexate—colon cancer	0.00147	0.00147	CcSEcCtD
Fosfomycin—Dermatitis—Methotrexate—colon cancer	0.00147	0.00147	CcSEcCtD
Fosfomycin—Headache—Methotrexate—colon cancer	0.00146	0.00146	CcSEcCtD
Fosfomycin—Nausea—Methotrexate—colon cancer	0.00139	0.00139	CcSEcCtD
